David B. Bylund - Publications

Affiliations: 
University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Pharmacology, Mental Health, Behavioral Psychology

70 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Bylund DB, Enna SJ. Receptor Binding Assays and Drug Discovery. Advances in Pharmacology (San Diego, Calif.). 82: 21-34. PMID 29413522 DOI: 10.1016/Bs.Apha.2017.08.007  0.336
2011 Bylund DB, Toews ML. Radioligand binding methods for membrane preparations and intact cells. Methods in Molecular Biology (Clifton, N.J.). 746: 135-64. PMID 21607856 DOI: 10.1007/978-1-61779-126-0_8  0.331
2010 Montgomery MD, Bylund DB. Lack of effect of the alpha2C-adrenoceptor Del322-325 polymorphism on inhibition of cyclic AMP production in HEK293 cells. British Journal of Pharmacology. 159: 820-30. PMID 20128806 DOI: 10.1111/J.1476-5381.2009.00584.X  0.687
2009 Balogh B, Szilágyi A, Gyires K, Bylund DB, Mátyus P. Molecular modelling of subtypes (alpha(2A), alpha(2B) and alpha(2C)) of alpha(2)-adrenoceptors: a comparative study. Neurochemistry International. 55: 355-61. PMID 19447153 DOI: 10.1016/J.Neuint.2009.05.004  0.384
2009 Reed AL, Anderson JC, Bylund DB, Petty F, El Refaey H, Happe HK. Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats. Psychopharmacology. 205: 249-59. PMID 19387616 DOI: 10.1007/S00213-009-1535-2  0.678
2008 Deupree JD, Burke WJ, Bylund DB. Alpha-2 adrenergic-induced changes in rectal temperature in adult and 13-day old rats following acute and repeated desipramine administration. Bmc Pharmacology. 8: 17. PMID 18831759 DOI: 10.1186/1471-2210-8-17  0.35
2008 Reed AL, Happe HK, Petty F, Bylund DB. Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression. Psychopharmacology. 197: 433-41. PMID 18180907 DOI: 10.1007/S00213-007-1052-0  0.676
2008 Kozisek ME, Middlemas D, Bylund DB. The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment. Neuropharmacology. 54: 251-7. PMID 18048068 DOI: 10.1016/J.Neuropharm.2007.08.001  0.338
2008 Kozisek ME, Middlemas D, Bylund DB. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacology & Therapeutics. 117: 30-51. PMID 17949819 DOI: 10.1016/J.Pharmthera.2007.07.001  0.326
2007 Bylund DB, Kozisek ME, Montgomery MD, Reed AL. Today's research, tomorrow's health: focus on pharmacogenomics. Personalized Medicine. 4: 363-367. PMID 29788667 DOI: 10.2217/17410541.4.3.363  0.678
2007 Deupree JD, Montgomery MD, Bylund DB. Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram. European Journal of Pharmacology. 576: 55-60. PMID 17850785 DOI: 10.1016/J.Ejphar.2007.08.017  0.692
2007 Bylund DB, Reed AL. Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs? Neurochemistry International. 51: 246-53. PMID 17664028 DOI: 10.1016/J.Neuint.2007.06.025  0.682
2007 Kozisek ME, Deupree JD, Burke WJ, Bylund DB. Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies. Journal of Neuroscience Methods. 163: 83-91. PMID 17400296 DOI: 10.1016/J.Jneumeth.2007.02.015  0.327
2007 Murrin LC, Sanders JD, Bylund DB. Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. Biochemical Pharmacology. 73: 1225-36. PMID 17316571 DOI: 10.1016/J.Bcp.2007.01.028  0.342
2007 Deupree JD, Reed AL, Bylund DB. Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats. The Journal of Pharmacology and Experimental Therapeutics. 321: 770-6. PMID 17293562 DOI: 10.1124/Jpet.106.118935  0.715
2007 Montgomery MD, Taylor CK, Deupree JD, Bylund DB. Effect of alpha‐2C adrenergic receptor Del322‐325 polymorphism on cyclic AMP production in HEK293 cells The Faseb Journal. 21. DOI: 10.1096/fasebj.21.5.a423-c  0.674
2006 Sanders JD, Szot P, Weinshenker D, Happe HK, Bylund DB, Murrin LC. Analysis of brain adrenergic receptors in dopamine-beta-hydroxylase knockout mice. Brain Research. 1109: 45-53. PMID 16854392 DOI: 10.1016/J.Brainres.2006.06.033  0.373
2005 Grunewald GL, Romero FA, Seim MR, Criscione KR, Deupree JD, Spackman CC, Bylund DB. Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoquinolines. Bioorganic & Medicinal Chemistry Letters. 15: 1143-7. PMID 15686930 DOI: 10.1016/J.Bmcl.2004.12.013  0.303
2005 Bylund DB. Alpha-2 adrenoceptor subtypes: are more better? British Journal of Pharmacology. 144: 159-60. PMID 15655520 DOI: 10.1038/Sj.Bjp.0706060  0.356
2005 Sanders JD, Happe HK, Bylund DB, Murrin LC. Development of the norepinephrine transporter in the rat CNS Neuroscience. 130: 107-117. PMID 15561429 DOI: 10.1016/J.Neuroscience.2004.09.014  0.312
2002 Scofield MA, Deupree JD, Bylund DB. Adrenergic receptor genes: cDNA and genomic library construction. Molecular Biotechnology. 21: 171-97. PMID 12059116 DOI: 10.1385/Mb:21:2:171  0.351
2002 Deupree JD, Borgeson CD, Bylund DB. Down-regulation of the alpha-2C adrenergic receptor: involvement of a serine/threonine motif in the third cytoplasmic loop. Bmc Pharmacology. 2: 9. PMID 11926967 DOI: 10.1186/1471-2210-2-9  0.4
2001 Happe HK, Bylund DB, Murrin LC. Agonist-stimulated [35S]GTPgammaS autoradiography: optimization for high sensitivity. European Journal of Pharmacology. 422: 1-13. PMID 11430907 DOI: 10.1016/S0014-2999(01)01043-3  0.377
2001 Bylund DB, Gerety ME, Happe HK, Murrin LC. A robust GTP-induced shift in alpha(2)-adrenoceptor agonist affinity in tissue sections from rat brain. Journal of Neuroscience Methods. 105: 159-66. PMID 11275272 DOI: 10.1016/S0165-0270(00)00358-7  0.371
2001 Bylund DB. UNIT 1.5 Characterization of Adrenoceptors Current Protocols in Pharmacology. DOI: 10.1002/0471141755.Ph0105S00  0.373
2000 Happe HK, Bylund DB, Murrin LC. α2-Adrenoceptor-stimulated GTPγS binding in rat brain: An autoradiographic study European Journal of Pharmacology. 399: 17-27. PMID 10876018 DOI: 10.1016/S0014-2999(00)00380-0  0.339
2000 Murrin LC, Gerety ME, Happe HK, Bylund DB. Inverse agonism at α2-adrenoceptors in native tissue European Journal of Pharmacology. 398: 185-191. PMID 10854829 DOI: 10.1016/S0014-2999(00)00317-4  0.321
2000 Deupree JD, Scofield MA, Bylund DB. Analyses of adrenergic receptor sequences. Methods in Molecular Biology (Clifton, N.J.). 126: 53-72. PMID 10685402 DOI: 10.1385/1-59259-684-3:53  0.321
2000 Scofield MA, Deupree JD, Bylund DB. Isolation of adrenergic receptor genes. Methods in Molecular Biology (Clifton, N.J.). 126: 37-51. PMID 10685401 DOI: 10.1385/1-59259-684-3:37  0.316
2000 Scofield MA, Deupree JD, Bylund DB. Construction of libraries for isolation of adrenergic receptor genes. Methods in Molecular Biology (Clifton, N.J.). 126: 3-35. PMID 10685400 DOI: 10.1385/1-59259-684-3:3  0.31
1999 Iversen PL, Cornish KG, Iversen LJ, Mata JE, Bylund DB. Bolus intravenous injection of phosphorothioate oligonucleotides causes hypotension by acting as alpha(1)-adrenergic receptor antagonists. Toxicology and Applied Pharmacology. 160: 289-96. PMID 10544063 DOI: 10.1006/Taap.1999.8771  0.388
1998 Heck DA, Bylund DB. Differential down-regulation of alpha-2 adrenergic receptor subtypes. Life Sciences. 62: 1467-72. PMID 9585120 DOI: 10.1016/S0024-3205(98)00091-5  0.397
1998 Shiue C, Pleus RC, Shiue GG, Rysavy JA, Sunderland JJ, Cornish KG, Young SD, Bylund DB. Synthesis and biological evaluation of [11C]MK-912 as an alpha2-adrenergic receptor radioligand for PET studies. Nuclear Medicine and Biology. 25: 127-33. PMID 9468027 DOI: 10.1016/S0969-8051(97)00167-4  0.393
1995 Bylund DB. Pharmacological characteristics of alpha-2 adrenergic receptor subtypes. Annals of the New York Academy of Sciences. 763: 1-7. PMID 7677317 DOI: 10.1111/J.1749-6632.1995.Tb32386.X  0.387
1994 Shekim WO, Bylund DB, Hodges K, Glaser R, Ray-Prenger C, Oetting G. Platelet alpha 2-adrenergic receptor binding and the effects of d-amphetamine in boys with attention deficit hyperactivity disorder. Neuropsychobiology. 29: 120-4. PMID 8022532 DOI: 10.1159/000119074  0.383
1993 Blaxall HS, Heck DA, Bylund DB. Molecular determinants of the alpha-2D adrenergic receptor subtype. Life Sciences. 53: PL255-9. PMID 8412494 DOI: 10.1016/0024-3205(93)90600-8  0.396
1993 Bylund DB, Toews ML. Radioligand binding methods practical guide and tips American Journal of Physiology - Lung Cellular and Molecular Physiology. 265. PMID 8238529 DOI: 10.1152/Ajplung.1993.265.5.L421  0.362
1992 Lawhead RG, Blaxall HS, Bylund DB. Alpha-2A is the predominant alpha-2 adrenergic receptor subtype in human spinal cord. Anesthesiology. 77: 983-91. PMID 1359811 DOI: 10.1097/00000542-199211000-00022  0.377
1992 Wamsley JK, Alburges ME, Hunt MA, Bylund DB. Differential localization of alpha 2-adrenergic receptor subtypes in brain. Pharmacology, Biochemistry, and Behavior. 41: 267-73. PMID 1349434 DOI: 10.1016/0091-3057(92)90097-Y  0.309
1992 Bylund DB. Subtypes of alpha 1- and alpha 2-adrenergic receptors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 6: 832-9. PMID 1346768 DOI: 10.1096/Fasebj.6.3.1346768  0.414
1992 Lawhead RG, Blaxall HS, Bylund DB. THE PREDOMINANT ALPHA-2 ADRENERGIC RECEPTOR SUBTYPE IN HUMAN SPINAL CORD IS ALPHA-2A Anesthesiology. 77: A790. DOI: 10.1097/00000542-199209001-00790  0.34
1992 Bylund D. Subtypes of alpha-1 and alpha-2 adrenergic receptors European Neuropsychopharmacology. 2: 229-230. DOI: 10.1016/0924-977X(92)90079-N  0.376
1990 Rudeen PK, Creighton JA, Bylund DB, Petterborg LJ, Paredez S. Effects of light and an alpha-2-adrenergic agonist on serotonin N-acetyltransferase activity in chick pineal gland. Journal of Neural Transmission. General Section. 82: 119-29. PMID 1977416 DOI: 10.1007/Bf01245168  0.311
1990 Jones SB, Bylund DB. Effects of α2-Adrenergic agonist preincubation on subsequent forskolin-stimulated adenylate cyclase activity and [3H]forskolin binding in membranes from HT29 cells Biochemical Pharmacology. 40: 871-877. PMID 1974763 DOI: 10.1016/0006-2952(90)90329-J  0.332
1988 Bylund DB. Sub types of α2-adrenoceptors: Pharmacological and molecular biological evidence converg Trends in Pharmacological Sciences. 9: 356-361. PMID 2855960 DOI: 10.1016/0165-6147(88)90254-4  0.305
1987 Burns TW, Langley PE, Terry BE, Bylund DB, Forte LR. Comparative effects of forskolin and isoproterenol on the cyclic AMP content of human adipocytes. Life Sciences. 40: 145-54. PMID 3025542 DOI: 10.1016/0024-3205(87)90353-5  0.307
1986 Turner JT, Jones SB, Bylund DB. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29. Peptides. 7: 849-54. PMID 3025826 DOI: 10.1016/0196-9781(86)90105-1  0.335
1986 Petrash AC, Bylund DB. Alpha-2 adrenergic receptor subtypes indicated by [3H]yohimbine binding in human brain. Life Sciences. 38: 2129-37. PMID 3012234 DOI: 10.1016/0024-3205(86)90212-2  0.428
1986 Kawahara RS, Byington KH, Bylund DB. p-Azidoclonidine: a photoaffinity label for the alpha 2-adrenoceptor. European Journal of Pharmacology. 117: 43-50. PMID 3002802 DOI: 10.1016/0014-2999(85)90470-4  0.383
1986 Jones SB, Bylund DB. Ascorbic acid inhibition of alpha-adrenergic receptor binding Biochemical Pharmacology. 35: 595-599. PMID 2868730 DOI: 10.1016/0006-2952(86)90353-9  0.317
1985 Jones AW, Smith JM, Bylund DB, Garwitz ET. Membrane transport in vascular smooth muscle and its relation to normal and altered excitation during hypertension. Annals of Biomedical Engineering. 11: 589-98. PMID 6680278 DOI: 10.1007/Bf02364088  0.313
1985 Bylund DB, Solomon N, Ray-Prenger C, Jones SB, Harris RA. Comparison of adrenergic receptor binding in blood cells from alcoholics and controls. Alcohol (Fayetteville, N.Y.). 1: 369-72. PMID 6537222 DOI: 10.1016/0741-8329(84)90005-3  0.357
1985 Bylund DB. Heterogeneity of alpha-2 adrenergic receptors. Pharmacology, Biochemistry, and Behavior. 22: 835-43. PMID 2989948 DOI: 10.1016/0091-3057(85)90536-2  0.415
1985 Walkenbach RJ, Chao WT, Bylund DB, Gibbs SR. Characterization of beta-adrenergic receptors in fresh and primary cultured bovine corneal endothelium. Experimental Eye Research. 40: 15-21. PMID 2984031 DOI: 10.1016/0014-4835(85)90104-6  0.33
1984 Walkenbach RJ, Gibbs SR, Bylund DB, Chao WT. Characteristics of beta-adrenergic receptors in bovine corneal epithelium: comparison of fresh tissue and cultured cells. Biochemical and Biophysical Research Communications. 121: 664-72. PMID 6329207 DOI: 10.1016/0006-291X(84)90233-X  0.336
1984 Turner JT, Pierce DL, Bylund DB. Alpha-2 adrenergic regulation of norepinephrine release in the rat submandibular gland as measured by HPLC-EC. Life Sciences. 35: 1385-94. PMID 6148676 DOI: 10.1016/0024-3205(84)90396-5  0.392
1983 Martinez JR, Bylund DB, Mawhinney T, Camden J, Ray G. The chronically reserpinized rat as a model for cystic fibrosis: alterations in the mucus-secreting sublingual gland. Pediatric Research. 17: 523-8. PMID 6622094 DOI: 10.1203/00006450-198307000-00001  0.348
1983 Jones SB, Bylund DB, Rieser CA, Shekim WO, Byer JA, Carr GW. alpha 2-Adrenergic receptor binding in human platelets: alterations during the menstrual cycle. Clinical Pharmacology and Therapeutics. 34: 90-6. PMID 6305547 DOI: 10.1038/Clpt.1983.135  0.405
1983 Feller DJ, Schroeder F, Bylund DB. Binding of [3H]flunitrazepam to the LM cell, a transformed murine fibroblast Biochemical Pharmacology. 32: 2217-2223. PMID 6135424 DOI: 10.1016/0006-2952(83)90229-0  0.316
1983 Bylund DB, U'Prichard DC. Characterization of α1-and α2-Adrenergic Receptors International Review of Neurobiology. 24: 343-431. DOI: 10.1016/S0074-7742(08)60225-1  0.356
1982 Bylund DB, Martinez JR, Camden J, Jones SB. Autonomic receptors in the developing submandibular glands of neonatal rats. Archives of Oral Biology. 27: 945-50. PMID 6297437 DOI: 10.1016/0003-9969(82)90101-7  0.391
1982 Martinez JR, Bylund DB, Camden J. Characterization of autonomic receptors in the rat sublingual gland by biochemical and radioligand assays. Naunyn-Schmiedeberg's Archives of Pharmacology. 318: 313-8. PMID 6281669 DOI: 10.1007/Bf00501171  0.365
1982 Burns TW, Langley PE, Terry BE, Bylund DB. Studies on desensitization of adrenergic receptors of human adipocytes. Metabolism: Clinical and Experimental. 31: 288-93. PMID 6281616 DOI: 10.1016/0026-0495(82)90067-1  0.391
1982 Burns TW, Langley PE, Terry BE, Bylund DB, Forte LR. Alpha-2 adrenergic activation inhibits forskolin-stimulated adenylate cyclase activity and lipolysis in human adipocytes. Life Sciences. 31: 815-21. PMID 6127588 DOI: 10.1016/0024-3205(82)90709-3  0.312
1982 Latifpour J, Bylund DB. Characterization of alpha-adrenergic receptors in rat lung membranes: presence of alpha 1 but not alpha 2 receptors. Biochemical Pharmacology. 30: 2623-5. PMID 6118155 DOI: 10.1016/0006-2952(81)90593-1  0.385
1981 Burns TW, Langley PE, Terry BE, Bylund DB, Hoffman BB, Tharp MD, Lefkowitz RJ, García-Saínz JA, Fain JN. Pharmacological characterizations of adrenergic receptors in human adipocytes. The Journal of Clinical Investigation. 67: 467-75. PMID 6257762 DOI: 10.1172/Jci110055  0.417
1980 Bylund DB, Martinez JR. alpha 2-Adrenergic receptors appear in rat salivary glands after reserpine treatment. Nature. 285: 229-30. PMID 6246446 DOI: 10.1038/285229A0  0.446
1979 Bylund DB. Regulation of central adrenergic receptors. Advances in Experimental Medicine and Biology. 116: 133-62. PMID 224667 DOI: 10.1007/978-1-4684-3503-0_8  0.35
1979 Bennett JP, Enna SJ, Bylund DB, Gillin JC, Wyatt RJ, Snyder SH. Neurotransmitter receptors in frontal cortex of schizophrenics. Archives of General Psychiatry. 36: 927-34. PMID 37813 DOI: 10.1001/Archpsyc.1979.01780090013001  0.34
1978 Bylund DB. beta-adrenergic receptor binding in guinea pig cerebral cortex. Brain Research. 152: 391-5. PMID 28171 DOI: 10.1016/0006-8993(78)90270-6  0.32
Show low-probability matches.